Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.120
-0.050 (-4.27%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Inovio Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Inovio Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $5.83. The average 1-year stock price forecast is 420.54% higher than the current stock price, while the lowest is $1.80 (+60.71%) and the highest is $13 (+1,060.71%).
Price Target: $5.83 (+420.54%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 1, 2026.
Analyst Ratings
The average analyst rating for Inovio Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $2.5 | Hold | Reiterates | $2.5 | +123.21% | Jun 1, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $6 | Buy | Reiterates | $6 | +435.71% | May 22, 2026 |
Financial Forecast
Revenue This Year
10.88M
from 65.34K
Increased by 16,551.75%
Revenue Next Year
69.07M
from 10.88M
Increased by 534.83%
EPS This Year
-1.14
from -1.82
EPS Next Year
-0.41
from -1.14
EPS and Forward PE are based on non-GAAP adjusted numbers.